Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
A. Turan at al Feb 2006 Turkey | 40 patients undergoing lower extremity surgery procedures | 40 patients undergoing lower extremity surgery procedures were randomly assigned to receive (i) placebo capsules (control) or (ii) gabapentin (1.2 g day–1) before and for 2 days after surgery. | verbal rating scale scoring for pain and sedation, PCEA usage, quality of recovery assessment, times of GI function recovery, and patient satisfaction scoring for pain management | Pain scores at 1, 4, 8, 12, and 16 h (P<0.001), PCEA bolus requirements (n) at 24 and 72 (P<0.05) and paracetamol (mg) consumption; P<0.05), were significantly lower in the gabapentin-treated patients than in the control group. Patient satisfaction was better in gabapentin-treated patients. Gabapentin-treated patients had less motor block when compared with control group. Times of return of bowel function, hospitalization, and resumption of dietary intake were similar in the groups. However, the incidence of dizziness was higher in the gabapentin group (35% vs 5%; P<0.05). | |
Ménigaux et al, May 2005 France | arthroscopic anterior cruciate ligament repair; 40 patients | 40 patients were randomly assigned to receive 1200 mg oral gabapentin or placebo 1–2 h before surgery;PCA morphine for postop pain relief | Pain scores and morphine consumption were recorded over 48 h. Degrees of active and passive knee flexion and extension were recorded during physiotherapy on days 1 and 2. | Preoperative anxiety scores were less in the gabapentin than control group (visual analog scale scores of 28 ± 16 mm versus 66 ± 15 mm, respectively; P < 0.001). The gabapentin group required less morphine than the control group (29 ± 22 mg versus 69 ± 40 mg, respectively; P < 0.001). Visual analog scale pain scores at rest and after mobilization were significantly reduced in the gabapentin group. First and maximal passive and active knee flexions at 24 and 48 h were significantly more extensive in the gabapentin than in the control group | |
Dirks et al, September 2002 Denmark | Radical mastectomy; 70 patients | Radical mastectomy; 70 patients received a single dose of oral gabapentin (1,200 mg) or placebo 1 h before surgery; PCA morphine for postop pain relief | Pain relief(VAS),opioid consumption | A single dose of 1,200 mg oral gabapentin resulted in a substantial reduction in postoperative morphine consumption and movement-related pain after radical mastectomy, without significant side effects | |
Dierking et al, 2004 Mar Denmark | 80 patients ,abdominal hysterectomy | 80 patients received oral gabapentin 1200 mg or placebo 1 h before surgery(abdominal hysterectomy), followed by oral gabapentin 600 mg or placebo 8, 16 and 24 h after the initial dose, PCA for postop pain | Pain relief(VAS), nausea, somnolence and dizziness on a four-point verbal scale, and vomiting | Gabapentin in a total dose of 3000 mg, administered before and during the first 24 h after abdominal hysterectomy, reduced morphine consumption with 32%, without significant effects on pain scores | |
Rorarius et al, 2004 Jul Finland | elective vaginal hysterectomy | 1200 mg of gabapentin or 15 mg of oxazepam (active placebo) 2.5 h prior to induction of anaesthesia to patients undergoing elective vaginal hysterectomy | Pain scores, opioid consumption, side effects | Gabapentin reduced the need for additional postoperative pain treatment (PCA boluses of 50 microg of fentanyl) by 40% during the first 20 postoperative hours. During the first 2 postoperative hours pain scores at rest and worst pain score (VAS 0-100 mm) were significantly higher in the active placebo group compared to the gabapentin-treated patients. Additionally, pretreatment with gabapentin reduced the degree of postoperative nausea and incidence of vomiting/retching possibly either due to the diminished need for postoperative pain treatment with opioids or because of an anti-emetic effect of gabapentin itself. No preoperative differences between the two groups were encountered with respect to the side effects of the premedication | |
Radhakrishnan et al, July 2005 India | lumbar laminectomy and discectomy; 60 adult patients | lumbar laminectomy and discectomy; gabapentin 800 mg (in two equally divided doses) or placebo was given preoperatively to 60 adult patients; PCA morphine | Pain at rest and on movement was assessed using a Verbal Rating Scale (VRS) every 2 hours for the first 8 postoperative hours | Gabapentin does not decrease the morphine requirement or morphine side effects in the immediate postoperative period following lumbar laminectomy and discectomy. | |
Pandey et al, April 2005 India | 100 patients for lumbar discectomy | 100 patients were divided into five groups to receive placebo or gabapentin 300, 600, 900, or 1200 mg 2 hours before lumbar diskectomy. After surgery, patients were transferred to the postanesthesia care unit (PACU). A blinded anesthesiologist recorded the pain scores at time points of 6, 12, 18, and 24 hours in the PACU on a Visual Analog Scale (VAS; 0-10 cm) at rest. Patients received patient-controlled analgesia (fentanyl 1.0 [mu]g/kg on each demand with lockout interval of 10 minutes); total fentanyl consumption during initial 24 hours was recorded | Pain scores, opioid consumption | gabapentin 600 mg is the optimal dose for postoperative pain relief following lumbar diskectomy | |
Chandra Kant Pandey et al, April 2004 India | 459 patients, laparoscopic cholecystectomy | 459 ASA I and II patients were randomly assigned to receive 300 mg gabapentin, 100 mg tramadol or placebo in a double-blind manner two hours before laparoscopic cholecystectomy under general anesthesia. Patients received fentanyl 2 micro g*kg(-1) intravenously on demand. | Pain relief(VAS), opioid consumption | Patients in the gabapentin group had significantly lower pain scores at all time intervals in comparison to tramadol and placebo. Significantly less fentanyl was consumed in the gabapentin group than in the tramadol and placebo groups. Sedation (33.98%), nausea/retching/vomiting (24.8%) were the commonest side effects in the gabapentin group whereas respiratory depression (3.9%) was the commonest in the tramadol group and vertigo (7.8%) in the placebo group. | |
Turan et al, Jan 2006 Turkey | 100 patients undergoing abdominal hysterectomy | 100 patients undergoing abdominal hysterectomy procedures were randomly assigned to one of four treatment groups: 1) control group received placebo capsules and pills before and for 2 days after surgery, 2) rofecoxib group received 50 mg/d PO and placebo capsules before and after surgery and, 3) gabapentin group received 1.2 g/d PO and placebo pills before and after surgery, and 4) combination group received rofecoxib 50 mg/d and gabapentin 1.2 g/d PO before and after surgery | Recovery,Pain relief, opioid consumption, sedation, recovery of bowel function | Gabapentin (1.2 g/d PO) appears to be an acceptable alternative to rofecoxib (50 mg/d PO) for short-term use as an adjuvant to opioid analgesics in patients undergoing lower abdominal surgery |